Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. [electronic resource]
Producer: 20070514Description: 237-48 p. digitalISSN:- 0022-3565
- Animals
- Anti-Anxiety Agents
- Antidepressive Agents
- Antidepressive Agents, Tricyclic -- metabolism
- Antimetabolites
- Anxiety -- drug therapy
- Bromodeoxyuridine
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Citalopram -- metabolism
- Drug Evaluation, Preclinical
- Feeding Behavior -- drug effects
- Hippocampus -- cytology
- Imipramine -- metabolism
- Immunohistochemistry
- Male
- Mice
- Mice, Inbred BALB C
- Motor Activity -- drug effects
- Neurons -- drug effects
- Piperidines -- pharmacology
- Receptors, Somatostatin -- antagonists & inhibitors
- Selective Serotonin Reuptake Inhibitors -- metabolism
- X-Rays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.